Shanghai, China – June 30, 2026 – As the global scar care market continues to expand, Cmallbio has strengthened its position in the international medical sector with its independently developed reusable silicone gel scar dressing. Combining medical-grade silicone technology with clinically proven scar management principles, the company is bringing high-quality scar care solutions from China to healthcare professionals and consumers worldwide.
The worldwide silicone gel scar dressing market has maintained steady growth in recent years. Industry data indicates that the market was valued at approximately US$1.378 billion in 2024 and is expected to reach US$3.5 billion by 2035. Market expansion is being driven by increasing surgical procedures, a growing number of burn and trauma cases, and rising consumer awareness of scar appearance and long-term skin care.
Medical silicone gel scar dressings have become a widely recommended first-line, non-invasive scar management option due to their established safety profile and clinical effectiveness in managing hypertrophic scars and keloids.
Cmallbio's silicone gel scar dressing is manufactured from premium medical-grade silicone rubber, creating a soft, flexible, and self-adhesive silicone gel sheet that comfortably conforms to flat skin surfaces and body joints. By creating an occlusive hydration environment over the scar, the dressing helps regulate collagen production, soften and flatten raised scars, reduce itching and discomfort, and support the skin's natural healing process.
One of the product's key advantages is its reusable design. With proper cleaning and maintenance, each silicone gel scar dressing can be reused for up to 28 days. This significantly lowers long-term treatment costs while reducing product waste, making it an environmentally friendly solution for long-term scar management.
The dressing features excellent self-adhesion without requiring additional medical tape and can be easily removed, washed, and reapplied, improving patient comfort, convenience, and treatment compliance.
Cmallbio manufactures its silicone gel scar dressings under strict medical-grade quality standards. The silicone material is produced using technology backed by decades of clinical application, with manufacturing systems designed to meet internationally recognized quality requirements. From raw material selection through finished product inspection, comprehensive quality control ensures consistent product performance, biocompatibility, and manufacturing reliability.
Cmallbio's silicone gel scar dressings are now supplied to customers across multiple countries and regions, supporting scar management in burn care, plastic surgery, obstetrics and gynecology, general surgery, and home healthcare applications. The company continues to expand its international distribution network while investing in product innovation to provide comprehensive scar care solutions covering early prevention, scar treatment, and long-term maintenance.
With growing awareness of scar management and increasing demand across emerging markets, particularly in the Asia-Pacific region, Cmallbio remains committed to advancing medical-grade silicone technology and delivering reliable, high-quality scar care products. Through continuous innovation and global market expansion, the company aims to help more patients effectively manage scars while supporting confidence and long-term skin health.
